Rayonier

RYN · NYSE

$18.81+$0.12 (+0.64%)TodayMarket closed ·
Prev close $18.69

RYN analyst rating

HoldConsensus of 5 analysts over the last 12 months. 20% rate it a buy.
  • Strong buy1
  • Buy0
  • Hold4
  • Underperform0
  • Sell0

12-month price target · 7 analysts

Average $26.52 (+41.0% upside)

Low
$23.23
Now
$18.81
High
$33.60

Upgrades and downgrades

The latest rating actions, newest first

RYN analyst upgrades, downgrades and rating actions
FirmDateActionRating
RBC CapitalOct 16, 2026MaintainsSector Perform
Truist SecuritiesOct 12, 2026MaintainsHold
CitigroupOct 5, 2026MaintainsNeutral
CitigroupAug 10, 2026MaintainsNeutral
Truist SecuritiesJul 15, 2026MaintainsHold
BMO CapitalMay 19, 2026MaintainsMarket Perform
CitigroupMay 13, 2026MaintainsNeutral
Truist SecuritiesMay 11, 2026MaintainsHold
RBC CapitalFeb 17, 2026MaintainsSector Perform
Raymond JamesFeb 13, 2026UpgradeOutperform → Strong Buy

The case for and against

Updated Oct 23, 2025

Bull case

Rayonier's positive outlook is supported by a 3% year-over-year increase in average delivered pulpwood prices, which have reached $30.05 per ton, attributed to improved supply and demand dynamics. Additionally, the company has seen a 7% year-over-year rise in average delivered prices for domestic sawtimber, now at $90.58 per ton, driven by strong domestic demand and favorable geographical factors. Management anticipates further enhancements in U.S. lumber production and timber pricing in the latter half of 2025 due to impending increases in softwood lumber duties on Canadian imports.

Bear case

Rayonier's average pine sawtimber and pulpwood stumpage realizations decreased by 16% and 17% year-over-year, respectively, driven by reduced demand from Southern sawmills and pulp mills, along with an influx of salvage timber and an unfavorable geographic mix. The company has revised its 2025 capital expenditures guidance downward from $72-77 million to $52-56 million, reflecting a significant reduction in expected investments. Furthermore, Rayonier's projected Adjusted EBITDA for Q2 2025 has been dramatically lowered to $30-40 million, down from an earlier estimate of $57.4 million, which indicates deteriorating financial expectations for the upcoming quarters.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.